CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 17,063,156	$ 20,380,504
Adjustments to reconcile net income to net cash used in operating activities:
Investment income earned on investments held in Trust Account	(330,519)	(40,379)
Offering costs associated with warrants recorded as liabilities	0	1,674,648
Change in fair value of warrant liabilities	(17,146,154)	(24,367,413)
Excess of fair value over cost on sale of Private Placement Warrants	0	2,146,129
Changes in operating assets and liabilities
Prepaid expenses	115,002	(925,360)
Accrued expenses	(913,204)	75,155
Accrued expenses - related party	(46,429)	12,500
Net cash used in operating activities	(1,258,148)	(1,044,216)
Cash flows from investing activities:
Cash deposited in Trust Account	0	(1,000,000,000)
Net cash used in investing activities	0	(1,000,000,000)
Cash flows from financing activities:
Proceeds received from working capital loan	1,000,000	0
Proceeds received from initial public offering, gross	0	1,000,000,000
Proceeds received from sale of Private Placement Warrants	0	23,000,000
Payment of underwriter commissions	0	(20,000,000)
Payment of offering costs	0	(765,091)
Net cash provided by financing activities	1,000,000	1,002,234,909
Net change in cash	(258,148)	1,190,693
Cash – beginning of period	749,510	0
Cash – end of period	491,362	1,190,693
Supplemental disclosure of non-cash activities
Accrued offering costs	0	103,855
Deferred underwriter’s commissions in connection with the initial public offering	$ 0	$ 35,000,000